Cas:1131594-33-6 methyl 3-bromo-4-[2-hydroxyethyl(methyl)amino]benzoate manufacturer & supplier

Chemical Name:methyl 3-bromo-4-[2-hydroxyethyl(methyl)amino]benzoate

CAS.NO:1131594-33-6

Synonyms:methyl 3-bromo-4-((2-hydroxyethyl)(methyl)amino)benzoate

Molecular Formula:C₁₁H₁₄BrNO₃

Molecular Weight:288.13800

HS Code:2922509090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:49.77000

Exact Mass:287.01600

LogP:1.66420

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like methyl 3-bromo-4-((2-hydroxyethyl)(methyl)amino)benzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 3-bromo-4-((2-hydroxyethyl)(methyl)amino)benzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 3-bromo-4-((2-hydroxyethyl)(methyl)amino)benzoate Use and application,methyl 3-bromo-4-((2-hydroxyethyl)(methyl)amino)benzoate technical grade,usp/ep/jp grade.

Related News: Additionally, because only small quantities of enzyme are required to catalyze a reaction, integrating them into production workflows can dramatically reduce raw material costs. In turn, these properties of enzymes translate to lower overall costs for manufacturing the final product. Further savings are realized through elimination of complicated protection/deprotection and activation steps, removal of the need for multiple, time-consuming purifications, and higher atom utilization to increase the percentage of reactants that become useful products. 1-(6-(1,6-dimethyl-2-oxo-1,2-dihydropyridin-4-yl)-4-(1H-pyrazol-1-yl)-1H-benzo[d]imidazol-2-yl)-3-ethylurea manufacturers Here’s how Biogen did during the three months ended June 30 compared with what Wall Street expected, according to average estimates compiled by Refinitiv. 1-(5-bromo-2-methyl-4-nitroimidazol-1-yl)propan-2-one suppliers Its approval has since been called into question, however, and the head of the FDA is now calling for a federal investigation looking into interactions between agency staff and the biotech company. 1-((9R,9aR)-9-(prop-1-en-2-yl)-9,9a-dihydroisoxazolo[4′,3′:4,5]benzo[1,2,3-cd]indol-4(6H)-yl)ethan-1-one vendor & factory.